6 patents
Utility
Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition
1 Aug 23
Disclosed are means of stimulating systemic immunity and reduction of post-surgery tumor metastasis through the concurrent intralymphatic inhibition of NR2F6 and treatment with cannabidiol.
Thomas Ichim, David Koos
Filed: 29 Sep 20
Utility
Suppression of pathological angiogenesis by inhibition of NR2F6
23 May 23
Disclosed are means, methods and compositions of matter useful for suppressing pathological production of new blood vessels in conditions such as cancer and wet macular degeneration.
Thomas Ichim, David Koos
Filed: 2 Nov 20
Utility
Small molecule modulators of NR2F6 activity
8 Feb 22
Disclosed are compounds useful for alteration of NR2F6 activity.
David Koos, Thomas Ichim
Filed: 29 Nov 16
Utility
Universal donor checkpoint inhibitor silenced/gene edited cord blood killer cells
12 Oct 21
Disclosed are compositions of matters, cells, and treatment protocols useful for induction of anticancer responses in a patient suffering from cancer.
Thomas Ichim, David Koos, Harry Lander
Filed: 21 Apr 17
Utility
Antigen specific mRNA cellular cancer vaccines
17 Aug 21
Disclosed are antigen specific cancer vaccines in which immunogenic epitopes are produced intracellularly by administration of modified mRNA encoding said immunogenic epitopes.
David Koos, Thomas Ichim
Filed: 23 May 16
Utility
Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibition
6 Jul 21
Disclosed are means, methods, and compositions of matter useful for generation of cancer inhibitory effector cells producing interleukin-17 (IL-17).
David Koos, Thomas Ichim, Santosh Kesari
Filed: 13 Feb 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first